99 related articles for article (PubMed ID: 7579135)
1. Synergistic effect of intrastriatal co-administration of L-NAME and quinolinic acid.
Galasso JM; Bazzett TJ; Becker JB; Albin RL
Neuroreport; 1995 Jul; 6(11):1505-8. PubMed ID: 7579135
[TBL] [Abstract][Full Text] [Related]
2. Modulation of quinolinic acid-induced depletion of striatal NADPH diaphorase and enkephalinergic neurons by inhibition of nitric oxide synthase.
Kalisch BE; Jhamandas K; Beninger RJ; Boegman RJ
Brain Res; 1999 Jan; 817(1-2):151-62. PubMed ID: 9889356
[TBL] [Abstract][Full Text] [Related]
3. Nomega-nitro-L-arginine, a nitric oxide synthase inhibitor, antagonizes quinolinic acid-induced neurotoxicity and oxidative stress in rat striatal slices.
Santamaría D; Espinoza-González V; Ríos C; Santamaría A
Neurochem Res; 1999 Jul; 24(7):843-8. PubMed ID: 10403623
[TBL] [Abstract][Full Text] [Related]
4. Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis.
Connop BP; Boegman RJ; Jhamandas K; Beninger RJ
Brain Res; 1995 Apr; 676(1):124-32. PubMed ID: 7540931
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity.
Pérez-Severiano F; Escalante B; Ríos C
Neurochem Res; 1998 Oct; 23(10):1297-302. PubMed ID: 9804286
[TBL] [Abstract][Full Text] [Related]
6. The neuronal NOS inhibitor L-MIN, but not 7-NINA, reduces neurotoxic effects of chronic intrastriatal administration of quinolinic acid.
Bazzett T; Geiger A; Coppola B; Albin R
Brain Res; 1997 Nov; 775(1-2):229-32. PubMed ID: 9439850
[TBL] [Abstract][Full Text] [Related]
7. The effect of nitric oxide synthase inhibition on quinolinic acid toxicity in the rat striatum.
MacKenzie GM; Jenner P; Marsden CD
Neuroscience; 1995 Jul; 67(2):357-71. PubMed ID: 7545792
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of malonate-induced degeneration of the nigrostriatal pathway by inhibitors of nitric oxide synthase.
Connop BP; Boegman RJ; Beninger RJ; Jhamandas K
Neuropharmacology; 1996 Apr; 35(4):459-65. PubMed ID: 8793908
[TBL] [Abstract][Full Text] [Related]
9. A dual role for nitric oxide in NMDA-mediated toxicity in vivo.
Globus MY; Prado R; Sanchez-Ramos J; Zhao W; Dietrich WD; Busto R; Ginsberg MD
J Cereb Blood Flow Metab; 1995 Nov; 15(6):904-13. PubMed ID: 7593350
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.
Pfeiffer S; Leopold E; Schmidt K; Brunner F; Mayer B
Br J Pharmacol; 1996 Jul; 118(6):1433-40. PubMed ID: 8832069
[TBL] [Abstract][Full Text] [Related]
11. Effects of N omega-nitro-L-arginine and L-arginine on quinolinic acid-induced lipid peroxidation.
Santamaría A; Santamaría D; Díaz-Muñoz M; Espinoza-González V; Ríos C
Toxicol Lett; 1997 Dec; 93(2-3):117-24. PubMed ID: 9486947
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia.
Buisson A; Margaill I; Callebert J; Plotkine M; Boulu RG
J Neurochem; 1993 Aug; 61(2):690-6. PubMed ID: 7687658
[TBL] [Abstract][Full Text] [Related]
13. Catalepsy induced by intra-striatal administration of nitric oxide synthase inhibitors in rats.
Del Bel EA; da Silva CA; Guimarães FS; Bermúdez-Echeverry M
Eur J Pharmacol; 2004 Feb; 485(1-3):175-81. PubMed ID: 14757138
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic nitric oxide synthase inhibition on TNB-induced colitis in rats.
Pfeiffer CJ; Qiu BS
J Pharm Pharmacol; 1995 Oct; 47(10):827-32. PubMed ID: 8583351
[TBL] [Abstract][Full Text] [Related]
15. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
16. Effect of NG-nitro-L-arginine methyl ester, the nitric oxide synthase inhibitor, on duodenal alkaline secretion and mepirizole-induced duodenal lesions in rats.
Takeuchi K; Takehara K; Kato S
J Clin Gastroenterol; 1995; 21 Suppl 1():S66-72. PubMed ID: 8774993
[TBL] [Abstract][Full Text] [Related]
17. NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release.
Inoue H; Arai I; Shibata S; Watanabe S
J Pharmacol Exp Ther; 1996 Jun; 277(3):1424-30. PubMed ID: 8667206
[TBL] [Abstract][Full Text] [Related]
18. Experiments with nitric oxide synthase inhibitors in spinal nerve ligated rats provide no evidence of a role for nitric oxide in neuropathic mechanical allodynia.
Lee DH; Singh JP; Lodge D
Neurosci Lett; 2005 Sep; 385(3):179-83. PubMed ID: 15964141
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide synthase inhibition and acute renal ischemia: effect on systemic hemodynamics and mortality.
Atanasova I; Burke TJ; McMurtry IF; Schrier RW
Ren Fail; 1995 Jul; 17(4):389-403. PubMed ID: 7569111
[TBL] [Abstract][Full Text] [Related]
20. Protection from inorganic mercury effects on the in vivo dopamine release by ionotropic glutamate receptor antagonists and nitric oxide synthase inhibitors.
Vidal L; Durán R; Faro LF; Campos F; Cervantes RC; Alfonso M
Toxicology; 2007 Sep; 238(2-3):140-6. PubMed ID: 17624650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
